Skandinaviska Enskilda Banken Ab (Publ) Vera Therapeutics, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $19.9 Billion
- Q1 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 22,290 shares of VERA stock, worth $441,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,290
Previous 22,290
-0.0%
Holding current value
$441,119
Previous $942,000
43.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
198Shares Held
63.7MCall Options Held
723KPut Options Held
193K-
Avoro Capital Advisors LLC New York, NY5.7MShares$113 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$94.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$66.1 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$58.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$57.8 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $535M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...